-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Kangzhi Pharmaceutical responded to investors on the interactive platform on the 3rd that the company has produced and sold montmorillonite, and the product has passed the consistency evaluation
of the quality and efficacy of generic drugs in early 2021.
At present, the company works overtime production through external recruitment, transfer of employees from other bases, adjustment of shifts, etc.
, to ensure the supply of
products.
of the quality and efficacy of generic drugs in early 2021.
At present, the company works overtime production through external recruitment, transfer of employees from other bases, adjustment of shifts, etc.
, to ensure the supply of
products.
The picture is from the interactive platform of the Shenzhen Stock Exchange
The picture is from the interactive platform of the Shenzhen Stock Exchange
In addition, Kangzhi Pharmaceutical also said in response to investors that the company's drugs are currently sold
domestically.
domestically.